 |
|
Antifibrinolytic Therapy in Patients With Aneurysmal Subarachnoid HemorrhageA Report of the Cooperative Aneurysm Study
Harold P. Adams, Jr, MD;
Donald W. Nibbelink, MD;
James C. Torner, MS;
A. L. Sahs, MD
Arch Neurol. 1981;38(1):25-29.
Abstract
• Antifibrinolytic therapy was used in 1,114 patients who had aneurysmal subarachnoid hemorrhage (SAH) and who were treated by the 13 institutions of the Cooperative Aneurysm Study. Patients were started on treatment within one week after SAH was diagnosed, and therapy was discontinued 14 days after the ictus. Rebleeding occurred in 10% of the treated patients. Overall mortality among the treated patients during the two weeks following hemorrhage was 10.7%. Though some minor and a few major side effects occurred, serious complications of therapy were infrequent.
Author Affiliations
From the Cooperative Aneurysm Study, Department of Neurology, University of Iowa, Iowa City. A list of additional participating investigators and their respective institutions follows in the "Acknowledgment" section.
Footnotes
Accepted for publication April 7, 1980.
Reprint requests to Cooperative Aneurysm Study, Department of Neurology, University of Iowa, Iowa City, IA 52242 (Dr Adams).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association
Bederson et al.
Stroke 2009;40:994-1025.
FULL TEXT
Current Strategies for the Management of Aneurysmal Subarachnoid Hemorrhage
Solomon and Fink
Arch Neurol 1987;44:769-774.
ABSTRACT
Antifibrinolytics in Aneurysmal Subarachnoid Hemorrhage: Do They Have a Role? Maybe
Adams
Arch Neurol 1987;44:114-115.
ABSTRACT
Antifibrinolytics in Subarachnoid Hemorrhage: Do They Have a Role? No
Weir
Arch Neurol 1987;44:116-118.
ABSTRACT
|
